ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 71 filers reported holding ALBIREO PHARMA INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $39,374,000 | +454.0% | 54,292 | -73.1% | 0.09% | +394.4% |
| Q1 2021 | $7,107,000 | -22.9% | 201,615 | -18.0% | 0.02% | -30.8% |
| Q4 2020 | $9,218,000 | +78.2% | 245,754 | +58.5% | 0.03% | +44.4% |
| Q3 2020 | $5,174,000 | +442.9% | 155,058 | +330.9% | 0.02% | +260.0% |
| Q2 2020 | $953,000 | +83.6% | 35,982 | +13.4% | 0.01% | +25.0% |
| Q1 2020 | $519,000 | -45.2% | 31,731 | -14.8% | 0.00% | +33.3% |
| Q4 2019 | $947,000 | +42.0% | 37,254 | +11.7% | 0.00% | +50.0% |
| Q3 2019 | $667,000 | -9.3% | 33,351 | +46.4% | 0.00% | 0.0% |
| Q2 2019 | $735,000 | -32.0% | 22,784 | -25.2% | 0.00% | -33.3% |
| Q2 2018 | $1,081,000 | – | 30,443 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 514,082 | $11,973,000 | 7.17% |
| Privium Fund Management B.V. | 379,117 | $8,959,000 | 1.78% |
| Birchview Capital, LP | 113,000 | $2,632,000 | 1.70% |
| Sio Capital Management, LLC | 213,913 | $4,982,000 | 1.50% |
| Perceptive Advisors | 4,720,278 | $109,936,000 | 0.85% |
| Chicago Capital, LLC | 849,239 | $19,779,000 | 0.74% |
| APOGEM CAPITAL LLC | 38,601 | $899,000 | 0.59% |
| Samsara BioCapital, LLC | 100,000 | $2,329,000 | 0.45% |
| Artal Group S.A. | 600,000 | $13,974,000 | 0.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 458,011 | $10,667,000 | 0.38% |